Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Turcot syndrome × Medroxyprogesterone Acetate × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 2 Turcot syndrome 1 Overweight 1 Obesity 1 Neoplasms 1 Endometrial Hyperplasia 1 Carcinoma, Endometrioid 1

Interventions

pembrolizumab 3 sintilimab 1 Surgical Procedures, Operative 1 Nivolumab 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Ipilimumab 1 Induction Chemotherapy 1 Immunotherapy 1 DEAE-Dextran 1 Colonoscopy 1 Chemotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06549855 2024-08-12

PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer

Peking University People's Hospital

Phase NA Not yet recruiting

Turcot syndrome, Endometrial Neoplasms, Carcinoma, Endometrioid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡